Prostate Cancer Clinical Trial

Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

Summary

In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 months followed by surgery to remove the prostate.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

High risk prostate cancer without evidence of bone metastasis.

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Study ID:

NCT00108290

Recruitment Status:

Completed

Sponsor:

US Department of Veterans Affairs

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

VA Maryland Health Care System
Baltimore Maryland, 21201, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Study ID:

NCT00108290

Recruitment Status:

Completed

Sponsor:


US Department of Veterans Affairs

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider